Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 147,051	$ 230,740
Marketable securities	355,743	253,175
Short-term deposits	45,280	49,800
Trade receivables (net of allowances of $1,135 and $1,487 at March 31, 2024 and December 31, 2023, respectively)	100,441	169,116
Prepaid expenses and other current assets	59,244	64,326
Total current assets	707,759	767,157
Long-term assets:
Long-term marketable securities	226,366	211,063
Operating lease right-of-use assets	49,220	51,838
Property and equipment, net	31,733	33,964
Intangible assets, net	881	1,263
Goodwill	23,135	23,135
Other assets	14,560	15,490
Total long-term assets	345,895	336,753
Total assets	1,053,654	1,103,910
Current liabilities:
Trade payables	2,899	672
Accrued expenses and other short-term liabilities	109,202	125,057
Deferred revenues	185,086	181,049
Total current liabilities	297,187	306,778
Long-term liabilities:
Convertible senior notes, net	250,860	250,477
Operating lease liabilities	48,009	51,313
Deferred revenues	403	886
Other liabilities	4,846	4,808
Total long-term liabilities	304,118	307,484
Stockholders’ equity:
Common stock of $0.001 par value - Authorized: 200,000,000 shares at March 31, 2024 and December 31, 2023; Issued and outstanding: 111,589,110 shares at March 31, 2024 and 109,103,721 shares at December 31, 2023	112	109
Accumulated other comprehensive loss	(9,105)	(8,649)
Additional paid-in capital	1,146,222	1,142,578
Accumulated deficit	(684,880)	(644,390)
Total stockholders’ equity	452,349	489,648
Total liabilities and stockholders’ equity	$ 1,053,654	$ 1,103,910